Please assess the completion status of the following clinical trial:

Trial Title: Role of Methane in Glycemic Control

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18-65 years old with pre-diabetes (hemoglobin a1c of 5.7-6.4%)~* BMI \> 25.0~* presence of methane on a breath sample (\>3ppm)~Exclusion Criteria:~Subjects will be excluded from the study if they exhibit any of the following:~* Diabetes/diabetes medications~* Prokinetic medication~* Pregnancy~* History of bariatric or intestinal surgery (other than cholecystectomy or appendectomy)~* Unstable thyroid disease~* An active weight loss treatment/plan~* Smoking~* Dietary restrictions (lactose intolerance, vegan etc)~* Other inability to comply with the study procedures, including known allergy to the study antibiotics (neomycin and rifaximin)~* Active inflammatory bowel disease (celiac, Crohn's disease, ulcerative colitis)~* Antibiotic use in the past month~* Subjects who do not have a microwave (for reheating study meals) and a freezer (for storing leftovers and stool samples) will be excluded from this study.~* Subjects who have an aspirin sensitivity~* Proton pump inhibitor medications or antacids~* History of bezoar~* Disorders of swallowing~* Suspected strictures, fistulas or physiological GI obstruction~* GI surgery within 3 months~* Severe dysphagia to food or pills~* Diverticulitis~* Subjects who use an implanted or portable electromechanical device such as a cardiac pacemaker or infusion pump~* Subject who have a peanut allergy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Obese/overweight, prediabetic methane positive (Type: EXPERIMENTAL): Neomycin Rifaximin

Based on this trial design, predict the completion outcome and termination type (if applicable).